Secondaries announced 10.29.2015
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Kura Oncology Symbol: KURA Price: Last trade $16.00 Description: Their common stock is quoted on the OTCQB under the symbol “KURO”[…]